Login / Signup

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.

Daisuke KuraiAkiko MizukamiVictor PrecklerFrederik VerelstDaniel MolnarTaizo MatsukiYufan HoAtaru Igarashi
Published in: Expert review of vaccines (2024)
RSVPreF3 OA vaccination is projected to have a substantial public health impact by reducing RSV-related morbidity and mortality in the OA population.
Keyphrases
  • public health
  • respiratory syncytial virus
  • knee osteoarthritis
  • global health
  • climate change
  • protein protein
  • binding protein
  • small molecule
  • data analysis